694 related articles for article (PubMed ID: 1829651)
1. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
[TBL] [Abstract][Full Text] [Related]
2. Lysis of murine macrophages by lymphokine-activated killer-like cells induced by BCG in vitro.
Chen MF; Suzuki H; Yano S
Microbiol Immunol; 1991; 35(7):557-67. PubMed ID: 1784257
[TBL] [Abstract][Full Text] [Related]
3. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
4. Non-MHC-restricted target-cell lysis by a CD4-CD8- TCR alpha beta T-cell line, as well as by TCR gamma delta T-cell lines, results from lymphokine-activated killing.
Maziarz RT; Groh V; Prendergast M; Fabbi M; Strominger JL; Burakoff SJ
Int J Cancer; 1991 Apr; 48(1):142-7. PubMed ID: 1902200
[TBL] [Abstract][Full Text] [Related]
5. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
[TBL] [Abstract][Full Text] [Related]
6. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules.
Rivas A; Koide J; Laus R; Engleman EG
J Immunol; 1990 Jul; 145(2):470-6. PubMed ID: 2142178
[TBL] [Abstract][Full Text] [Related]
7. The role of T cell receptors in non-MHC-restricted cytotoxicity.
Lauzon RJ; Siminovitch KA; Roder JC
Cell Immunol; 1989 Feb; 118(2):265-84. PubMed ID: 2521308
[TBL] [Abstract][Full Text] [Related]
8. Murine anti-CD3 monoclonal antibody induces potent cytolytic activity in both T and NK cell populations.
Stanková J; Hoskin DW; Roder JC
Cell Immunol; 1989 Jun; 121(1):13-29. PubMed ID: 2470516
[TBL] [Abstract][Full Text] [Related]
9. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A
Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897
[TBL] [Abstract][Full Text] [Related]
11. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine-activated killer (LAK) cells. VI. NK1.1+, CD3+ LAK effectors are derived from CD4-, CD8-, NK1.1- precursors.
Ballas ZK; Rasmussen W
Cell Immunol; 1991 May; 134(2):296-313. PubMed ID: 1827045
[TBL] [Abstract][Full Text] [Related]
13. LD1: a CD4-CD8- TCR alpha beta/CD3+ peripheral T cell line with helper function for B lymphocytes.
Pelkonen J; Palacios R
Int Immunol; 1990; 2(6):555-62. PubMed ID: 2150761
[TBL] [Abstract][Full Text] [Related]
14. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
15. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.
de Vries JE; Yssel H; Spits H
Immunol Rev; 1989 Jun; 109():119-41. PubMed ID: 2527803
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
Anderson PM; Blazar BR; Bach FH; Ochoa AC
J Immunol; 1989 Feb; 142(4):1383-94. PubMed ID: 2521662
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocyte triggering via CD16 is regulated by CD3 and CD8 antigens. Studies with T cell receptor (TCR)-alpha beta+/CD3+16+ and TCR-gamma delta+/CD3+16+ granular lymphocytes.
Oshimi K; Oshimi Y; Yamada O; Wada M; Hara T; Mizoguchi H
J Immunol; 1990 May; 144(9):3312-7. PubMed ID: 2139452
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
[TBL] [Abstract][Full Text] [Related]
19. Evidence for quantitative and qualitative differences in functional activation of Mls-reactive T cell clones and hybridomas by antigen or TcR/CD3 antibodies.
Gaugler B; Langlet C; Martin JM; Schmitt-Verhulst AM; Guimezanes A
Eur J Immunol; 1991 Oct; 21(10):2581-9. PubMed ID: 1680703
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
Cron RQ; Gajewski TF; Sharrow SO; Fitch FW; Matis LA; Bluestone JA
J Immunol; 1989 Jun; 142(11):3754-62. PubMed ID: 2523934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]